As shown in Fig. 2b, combination with anti-GARP:TGF-β1 WT improved the anti-tumor activity of anti-PD-1 in both WT and FcS formats (CR: 2/10 and 5/10 mice, respectively). The gene discussed is TGFB1; the disease is neoplasm.